Drug companies are quietly pushing through price hikes of 100% — or even more than 1,000% — for a very small but growing number of prescription drugs, helping to drive up costs for insurers, patients and government programs.
Among the examples: Questcor Pharmaceuticals last August raised the wholesale price on Acthar, which treats spasms in babies, from about $1,650 a vial to more than $23,000. Ovation raised the cost of Cosmegen, which treats a type of tumor, from $16.79 to $593.75 in January 2006.
The average wholesale price of 26 brand-name drugs jumped 100% or more in a single cost adjustment last year, up from 15 in 2004, the university study found. In the first half of this year, 17 drugs made the list.
As a new NFL season begins this Wednesday, the danger of America’s most-watched sport has never...
After recently gaining recognition as the first professional Santa Claus with Down syndrome in the US,...
US healthcare officials recently said a food-poisoning outbreak tied to alfalfa sprouts and involving multiple germs...
